NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Adenocarcinoma



Studies from Royal Liverpool University yield new data on adenocarcinoma



September 2nd, 2008

" The objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet-lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma. Materials and Methods Data were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy," researchers in Liverpool, the United Kingdom report.

" Both preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of <= 150 kU/l (or <= 300 kU/l in the presence of bilirubin levels > 35 mu mol/l) and a PLR of <= 160 were found to represent the...


Source: Cancer Weekly (2008-09-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login